Clinical trial • Not applicable • Neurology

Clinical trial in Multiple sclerosis

Not applicable trial for Multiple sclerosis. 60 participants.

Overview

Trial Therapeutic Area
Neurology
Trial Disease
Multiple sclerosis
Trial Stage
Not applicable

Key dates

Initial CTIS Submission Date
31-10-2024
First CTIS Authorization Date
03-12-2024

Trial design

Not applicable trial across 3 sites in France.

Target Sample Size
60

Recruitment

Planned Sample Size
60
Recruitment Window Months
47

Geography

Total Number Of Sites
3
Total Number Of Participants
60

France

Earliest CTIS Part Ii Submission Date
15-11-2024
Latest Decision Or Authorization Date
24-04-2025
Processing Time Days
160
Number Of Sites
3
Number Of Participants
60

Sites

Site Name
Groupe Hospitalier Nord Essonne
Department Name
CEA
Principal Investigator Name
Michel BOTTLAENDER
Principal Investigator Email
michel.bottlaender@cea.fr
Contact Person Name
Michel BOTTLAENDER
Contact Person Email
michel.bottlaender@cea.fr
Site Name
Assistance Publique Hopitaux De Paris
Department Name
Neurology
Principal Investigator Name
Bruno STANKOFF
Principal Investigator Email
bruno.stankoff@aphp.fr
Contact Person Name
Bruno STANKOFF
Contact Person Email
bruno.stankoff@aphp.fr
Site Name
Institut Du Cerveau Et De La Moelle Epiniere
Department Name
CIC
Principal Investigator Name
Céline LOUAPRE
Principal Investigator Email
celine.louapre@aphp.fr
Contact Person Name
Céline LOUAPRE
Contact Person Email
celine.louapre@aphp.fr

Sponsor

Primary sponsor

Full Name
Assistance Publique Hopitaux De Paris
Organisation Type
Hospital/Clinic/Other health care facility
Country Of Registered Address
France

Related trials

Other published trials that may interest you.